Craig Boerner
-
Phase 3 CELLEBRATE Trial testing regenerative stem cell-based therapy to improve urinary control for women
The Phase 3 CELLEBRATE trial to test a regenerative stem cell-based therapy in treating patients with stress urinary incontinence is continuing to recruit additional subjects after changing its study protocol to include only patients who have already tried surgery. Read MoreMar 11, 2024
-
Statins to be studied for prevention of dementia, disability and heart disease
Vanderbilt University Medical Center (VUMC) researchers are enrolling adults aged 75 and over to study whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor®, can help maintain health by preventing dementia, disability, and heart disease. Read MoreNov 17, 2020
-
Younger parents less likely to vaccinate their children and themselves against COVID-19
Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19. Read MoreNov 16, 2020
-
Glaucoma drug studied to prevent lung Infection in COVID-19 patients
Vanderbilt University Medical Center is evaluating razuprotafib, a drug used to treat glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19. Read MoreJun 24, 2020
-
All-in-one pill helps reduce blood pressure, cholesterol
A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study. Read MoreSep 19, 2019
-
Bladder pain syndrome no laughing matter for comedian
Local comedian Ashley Corby, 35, overshares with her audience as part of her standup routine, including a 5-minute bit about “shady” rest areas she has visited due to interstitial cystitis (IC), a bladder pain syndrome affecting 3 million to 8 million people in the United States. Read MoreMay 17, 2018
-
Study finds generic options offer limited savings for expensive drugs
Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released this week. Read MoreMay 9, 2018
-
Study spots undiagnosed genetic diseases in EHR
Patients diagnosed with heart failure, stroke, infertility and kidney failure could actually be suffering from rare and undiagnosed genetic diseases. Read MoreMar 15, 2018
-
Urological association taps Chang to help guide international strategy
The American Urological Association has announced three new assistant secretary positions, including Vanderbilt’s Sam Chang, MD, to better align its international growth. Read MoreMar 8, 2018
-
Saline use on decline at Vanderbilt following landmark studies
Vanderbilt University Medical Center is encouraging its medical providers to stop using saline as intravenous fluid therapy for most patients, a change provoked by two companion landmark studies released Feb. 27 that are anticipated to improve survival and decrease kidney complications. Read MoreFeb 27, 2018
-
Opioid use increases risk of serious infections
Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don’t use opioids. Read MoreFeb 12, 2018
-
Tennessee Poison Center celebrates 30th anniversary
The Tennessee Poison Center (TPC) is celebrating its 30th anniversary this month, following a year in which it received more than 50,000 emergency calls from residents, healthcare professionals, emergency departments and intensive care units. Read MoreFeb 12, 2018
-
Post-flu risks a growing concern for the elderly
Infectious disease experts are warning that flu can lead to an increased risk of heart attack, stroke and disability in elderly patients for months after they have recovered from their illness. Read MoreNov 21, 2017
-
Smoking study personalizes treatment
A simple blood test is allowing Vanderbilt University Medical Center (VUMC) researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch. Read MoreNov 16, 2017
-
Amoxicillin alone better choice for pediatric pneumonia: study
A combination of two antibiotics is often prescribed to treat community-acquired pneumonia in children, but a JAMA Pediatrics study is now showing that using just one of the two has the same benefit to patients in most cases. Read MoreNov 9, 2017
-
Edwards, Schaffner honored by major infectious diseases organizations
Two highly regarded Vanderbilt University Medical Center (VUMC) infectious disease clinicians were recognized with service awards from prominent organizations during IDWeek in San Diego, California, Oct. 4-8. Read MoreOct 26, 2017
-
View the eclipse safely; white Vanderbilt Health glasses recalled
VUMC has recalled the white eclipse safety glasses distributed at the Williamson County Fair over supply chain concerns. Multicolored Vanderbilt University, Dyer Observatory and Vanderbilt Eye Institute glasses were obtained from a different vendor and are not included in the recall. Read MoreAug 17, 2017
-
Uninsured emergency department visits down after Medicaid expansion
Fewer uninsured patients are walking through the doors of Emergency Departments in states that expanded Medicaid coverage under the Affordable Care Act (ACA), even though the total number of visits has increased since 2014, according to an Annals of Emergency Medicine study released Monday. Read MoreJun 19, 2017
-
Schaffner receives UpShot Award in vaccine communication
The National Vaccine Program Office in the U.S. Department of Health and Human Services has selected William Schaffner, M.D., to receive its 2017 NVPO UpShot Award in Vaccine Communication. Read MoreJun 15, 2017
-
VUMC’s Barocas honored by Society of Urologic Oncology
Daniel Barocas, M.D., associate professor of Urologic Surgery, recently received the Society of Urologic Oncology’s (SUO) Young Investigator Award at the group’s 2017 annual meeting in Boston. Read MoreMay 18, 2017